Activation of JNKs is essential for BMP9-induced osteogenic differentiation of mesenchymal stem cells
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Although BMP9 is highly capable of promoting osteogenic differentiation of mesenchymal stem cell (MSCs), the molecular mechanism involved remains to be fully elucidated. Here, we explore the possible involvement and detail role of JNKs (c-Jun N-terminal kinases) in BMP9-induced osteogenic differentiation of MSCs. It was found that BMP9 stimulated the activation of JNKs in MSCs. BMP9-induced osteogenic differentiation of MSCs was dramatically inhibited by JNKs inhibitor SP600125. Moreover, BMP9-activated Smads signaling was decreased by SP600125 treatment in MSCs. The effects of inhibitor are reproduced with adenoviruses expressing siRNA targeted JNKs. Taken together, our results revealed that JNKs was activated in BMP9-induced osteogenic differentiation of MSCs. What is most noteworthy, however, is that inhibition of JNKs activity resulted in reduction of BMP9-induced osteogenic differentiation of MSCs, implying that activation of JNKs is essential for BMP9 osteoinductive activity.
Abstract
Although BMP9 is highly capable of promoting osteogenic differentiation of mesenchymal stem cell (MSCs), the molecular mechanism involved remains to be fully elucidated. Here, we explore the possible involvement and detail role of JNKs (c-Jun N-terminal kinases) in BMP9-induced osteogenic differentiation of MSCs. It was found that BMP9 stimulated the activation of JNKs in MSCs. BMP9-induced osteogenic differentiation of MSCs was dramatically inhibited by JNKs inhibitor SP600125. Moreover, BMP9-activated Smads signaling was decreased by SP600125 treatment in MSCs. The effects of inhibitor are reproduced with adenoviruses expressing siRNA targeted JNKs. Taken together, our results revealed that JNKs was activated in BMP9-induced osteogenic differentiation of MSCs. What is most noteworthy, however, is that inhibition of JNKs activity resulted in reduction of BMP9-induced osteogenic differentiation of MSCs, implying that activation of JNKs is essential for BMP9 osteoinductive activity.
참고문헌 (23)
- Deng, Z. L., "Regulation of osteogenic differentiation during skeletal development", Front. Biosci, 13, pp.2001~2021 (2008)
- Hogan, B. L., "Bone morphogenetic proteins: multifunctional regulators of vertebrate development", Genes Dev, 10, pp.1580~1594 (1996)
- Chen, D., "Bone morphogenetic proteins", Growth Factors, 22, pp.233~241 (2004)
- Boraiah, S., "Complications of recombinant human BMP-2 for treating complex tibial plateau fractures: a preliminary report", Clin. Orthop. Relat. Res, 467, pp.3257~3262 (2009)
- Rutherford, R. B., "Bone morphogenetic protein 7 ex vivo gene therapy", Drug. News Perspect, 16, pp.5~10 (2003)
- Kang, Q., "Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus- mediated gene delivery", Gene Ther, 11, pp.1312~1320 (2004)
- Luu, H. H., "Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem cells", J. Orthop. Res, 25, pp.665~677 (2007)
- Luo, J., "TGFbeta", BMP type I receptors ALK1 and ALK2 are essential for BMP9-induced osteogenic signaling in mesenchymal stem cells, 2010, pp.285, 29588~29598
- Wu, N., "Identification and analysis of type II TGF-{beta} receptors in BMP-9-induced osteogenic differentiation of C3H10T1", 2 mesenchymal stem cells, 2010, pp.42, 699~708
- Heldin, C. H., "TGF-beta signaling from cell membrane to nucleus through SMAD proteins", Nature, 390, pp.465~471 (1997)
- Guicheux, J., "Activation of p38 mitogen- activated protein kinase and c-Jun-NH2-terminal kinase by BMP-2 and their implication in the stimulation of osteoblastic cell differentiation", J. Bone Miner. Res, 18, pp.2060~2068 (2003)
- Gallea, S., "Activation of mitogen-activated protein kinase cascades is involved in regulation of bone morphogenetic protein-2-induced osteoblast differentiation in pluripotent C2C12 cells", Bone, 28, pp.491~498 (2001)
- Liu, H., "Activation of c-Jun NH(2)-terminal kinase 1 increases cellular responsiveness to BMP-2 and decreases binding of inhibitory Smad6 to the type 1 BMP receptor", J. Bone Miner. Res, 26, pp.1122~1132 (2011)
- Huang, Y. F., "c-Jun N-terminal kinase 1 negatively regulates osteoblastic differentiation induced by BMP2 via phosphorylation of Runx2 at Ser104", J. Bone Miner. Res, 27, pp.1093~1105 (2012)
- Zhao, Y., "P38 and ERK1", 2 MAPKs act in opposition to regulate BMP9-induced osteogenic differentiation of mesenchymal progenitor cells, 2012, pp.7, e43383~
- Widmann, C., "Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human", Physiol. Rev, 79, pp.143~180 (1999)
- Song, J. J., "Bone morphogeneticprotein-9 binds to liver cells and stimulates proliferation", Endocrinology, 136, pp.4293~4297 (1995)
- López-Coviella, I., "Induction and maintenance of the neuronal cholinergic phenotype in the central nervous system by BMP9", Science, 289, pp.313~316 (2000)
- Chen, C., "An integrated functional genomics screening program reveals a role for BMP-9 in glucose homeostasis", Nat. Biotechnol, 21, pp.294~301 (2003)
- Truksa, J., "Bone morphogenetic proteins 2, 4, and 9 stimulate murine hepcidin 1 expression independently of Hfe, transferring receptor 2 (Tfr2), and IL-6", Proc. Natl. Acad. Sci. U.S.A, 103, pp.10289~10291 (2006)
- Li, C., "Bone morphogenetic protein-9 induces osteogenic differentiation of rat dental follicle stem cells in P38 and ERK1", 2 MAPK dependent manner, 2012, pp.9, 862~871
- Tian, X. Y., "Bone morphogenic protein-4 induces endothelial cell apoptosis through oxidative stress-dependent p38MAPK and JNK pathway", J. Mol. Cell Cardiol, 52, pp.237~244 (2012)
- Sovershaev, M. A., "Increased expression of TF in BMP-7-treated human mononuclear cells depends on activation of select MAPK signaling pathways", Thromb. Res, 128, pp.e154~e159 (2011)